{"nctId":"NCT02717273","briefTitle":"Surgical Site Infections After Liver Transplantation Based on Perioperative Antibiotics","startDateStruct":{"date":"2009-03"},"conditions":["Liver Transplantation","Surgical Site Infection"],"count":102,"armGroups":[{"label":"standard peri-operative antibiotics","type":"ACTIVE_COMPARATOR","interventionNames":["Drug: standard","Other: liver transplant"]},{"label":"extended three-day course of antibiotics","type":"EXPERIMENTAL","interventionNames":["Drug: extended","Other: liver transplant"]}],"interventions":[{"name":"standard","otherNames":["Peri-operative only antibiotics"]},{"name":"extended","otherNames":["Extended, three-day antibiotics"]},{"name":"liver transplant","otherNames":[]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* All patients â‰¥ 18 years of age.\n* Eligible for liver transplantation by UVA standard protocol.\n* First-time transplantation.\n* No active infections - requiring antibiotics - excluding antifungals.\n\nExclusion Criteria:\n\n* All patients \\< 18 years of age.\n* Previous liver transplantation.\n* Active infections - requiring antibiotics.\n* Allergy to all standard peri-operative antibiotics (piperacillin/tazobactam or UVA standard alternatives for Penicillin allergic patients: ciprofloxacin and vancomycin).","healthyVolunteers":false,"sex":"ALL","minimumAge":"18 Years","stdAges":["ADULT","OLDER_ADULT"]},"locations":{"multicenter":false},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Number of Subjects With Development of Surgical Site Infections","description":"development of surgical site infection, including superficial and deep incisional and organ space surgical site infections","paramType":"COUNT_OF_PARTICIPANTS","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"9","spread":null},{"groupId":"OG001","value":"13","spread":null}]}]}]},{"type":"SECONDARY","title":"Number of Subjects With Post-operative Fever","description":"fever above 38.5 degrees Celsius 24 hours after the end of the liver transplant","paramType":"COUNT_OF_PARTICIPANTS","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"6","spread":null},{"groupId":"OG001","value":"7","spread":null}]}]}]},{"type":"SECONDARY","title":"Number of Subjects With Elevated White Blood Count (WBC)","description":"above 15,000 within 24hours after the end of the liver transplant","paramType":"COUNT_OF_PARTICIPANTS","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"42","spread":null},{"groupId":"OG001","value":"41","spread":null}]}]}]},{"type":"SECONDARY","title":"Number of Subjects With Nosocomial Infection","description":"diagnosis of any new infection other than an SSI within 30 days from surgery","paramType":"COUNT_OF_PARTICIPANTS","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"8","spread":null},{"groupId":"OG001","value":"11","spread":null}]}]}]},{"type":"SECONDARY","title":"Length of Hospital Stay","description":"days hospitalized after liver transplant","paramType":"MEDIAN","dispersionType":"Inter-Quartile Range","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"7.5","spread":null},{"groupId":"OG001","value":"7.5","spread":null}]}]}]},{"type":"SECONDARY","title":"Number of Subjects With Graft Loss","description":"complete loss of liver function in recipient","paramType":"COUNT_OF_PARTICIPANTS","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"7","spread":null},{"groupId":"OG001","value":"6","spread":null}]}]}]},{"type":"SECONDARY","title":"Number of Subjects With Mortality","description":"death within 30 days of liver transplant","paramType":"COUNT_OF_PARTICIPANTS","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"1","spread":null},{"groupId":"OG001","value":"1","spread":null}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":0,"n":48},"commonTop":[]}}}